Concepedia
Statistics
Publications
19
Citations
1.9K
H-Index
16
Active since
2006
Affiliations
Takeda (United States)(Current)
Deerfield (United States)
University of California San Diego
SUNY Downstate Health Sciences University
University of Connecticut
Charlie Cao is an author at Takeda (United States) specializing in pharmacotherapy, pharmacology, and clinical pharmacology.
Publications per year
2006–2020
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
Todd W. Rice, Arthur P. Wheeler, Gordon R. Bernard et al. · Critical Care Medicine · 2010 · 498 citations · Full text
Veterinary Medicine, Pharmacology, Pharmacotherapy +17
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
Charles Burant, Prabhakar Viswanathan, John Marcinak et al. · The Lancet · 2012 · 245 citations
Medicine, Endocrinology, Pharmacotherapy +12
Effects of the Angiotensin Receptor Blocker Azilsartan Medoxomil Versus Olmesartan and Valsartan on Ambulatory and Clinic Blood Pressure in Patients With Stages 1 and 2 Hypertension
William B. White, Michael A. Weber, Domenic Sica et al. · Hypertension · 2011 · 215 citations
Medicine, Pharmacology, Pharmacotherapy +17
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease
Parambir S. Dulai, Brigid S. Boland, Siddharth Singh et al. · Gastroenterology · 2018 · 149 citations · Full text
Medicine, Clinical Sciences, Pharmacotherapy +14
The Comparative Effects of Azilsartan Medoxomil and Olmesartan on Ambulatory and Clinic Blood Pressure
George L. Bakris, Domenic Sica, Michael A. Weber et al. · Journal of Clinical Hypertension · 2011 · 141 citations · Full text
1–5 of 19